- 1.
Morrell MJ. Epilepsy in women: the science of why it is special. Neurology 1999; 53 (suppl 1): 42 – 8.
- 2.
Betts T. Managing epilepsy in young women. Curr Obstet Gynaecol 2000; 10: 202 – 7.
- 3.
Bäckström T, Rosciszewska D. Effects of hormones on seizure expression. I: Engel J, Pedley T red. Epilepsy: a comprehensive textbook. Philadelphia: Lippincott-Raven, 1997: 2003 – 12.
- 4.
Rosciszewska D. The course of epilepsy in girls at the age of puberty. Neurol Neurochir Pol 1975; 9: 597 – 602.
- 5.
Klein P. Onset of epilepsy at the time of menarche. Epilepsia 2001; 42 (suppl 7): 291 – 2.
- 6.
Shih TT, Flynn KL, Morrell MM, Pack AM, Done S. Menarche in women with epilepsy. Epilepsia 2001; 42 (suppl 7); 292 – 3.
- 7.
Svalheim S, Taubøll E, Bjørnenak T, Røste LS, Mørland T, Sætre E et al. Do women with epilepsy have an increased frequency of menstrual disturbances? Epilepsia 2002; 43 (suppl 7): 235.
- 8.
Morrell MJ. Effects of epilepsy on women’s reproductive health. Epilepsia 1998; 39 (suppl 8): 32 – 37.
- 9.
Herzog AG, Seibel MM, Schomer DL, Veitukaitis JL, Geschwind N. Reproductive endocrine disorders in women with partial seizures of temporal lobe origin. Arch Neurol 1986; 43: 341 – 6.
- 10.
Bilo L, Meo R, Nappi C, Annunziato L, Striano S, Colao AM et al. Reproductive endocrine disorders in women with primary generalized epilepsy. Epilepsia 1988; 29: 612 – 9.
- 11.
Herzog AG, Friedman MN. Menstrual cycle interval and ovulation in women with localization-related epilepsy. Neurology 2001; 57: 2133 – 5.
- 12.
Klein P, Herzog AG. Hormonal effects on epilepsy in women. Epilepsia 1998; 39 (suppl 8): 9 – 16.
- 13.
Pritchard PB III. Hormone changes in epilepsy. I: Engel J, Pedley T red. Epilepsy: a comprehensive textbook. Philadelphia: Lippincott-Raven, 1997: 1997 – 2002.
- 14.
Taubøll E. Hormones and antiepileptic drugs. Acta Neurol Scand 2000; 102 (suppl 175): 31 – 4.
- 15.
Isojärvi JIT, Laatikainen TJ, Pakarinen AJ, Juntunen KTS, Myllylä VV. Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy. N Engl J Med 1993; 329: 1383 – 8.
- 16.
Isojärvi JIT, Taubøll E, Pakarinen AJ, Van Parys J, Rättyä J, Harbo HF et al. Altered ovarian function and cardiovascular risks in valproate treated women. Am J Med 2001; 111: 290 – 6.
- 17.
Genton P, Bauer J, Duncan S, Taylor AE, Balen AH, Eberle A et al. On the association between valproate and polycystic ovary syndrome. Epilepsia 2001; 42: 295 – 304.
- 18.
Isojärvi JIT, Taubøll E, Tapanainen J, Pakarinen AJ, Laatikainen TJ, Knip M et al. On the association between valproate and polycystic ovary syndrome. Epilepsia 2001; 42: 295 – 304.
- 19.
Herzog AG, Schachter SC. Valproate and the polycystic ovarian syndrome: final thoughts. Epilepsia 2001; 42: 311 – 5.
- 20.
Bauer J, Isojärvi JIT, Herzog AG, Reuber M, Polson D, Taubøll E et al. Reproductive dysfunction in women with epilepsy: recommendations for evaluation and management. J Neurol Neurosurg Psychiatry 2002; 73: 121 – 5.
- 21.
Isojärvi JIT, Laatikainen TJ, Knip M, Pakarinen AJ, Juntunen KTS, Myllylä VV. Obesity and endocrine disorders in women taking valproate for epilepsy. Ann Neurol 1996; 39: 579 – 84.
- 22.
Murialdo G, Galimberti CA, Magri F, Sampaolo P, Copello F, Gianelli MV et al. Menstrual cycle and ovary alterations in women with epilepsy on antiepileptic therapy. J Endocrinol Invest 1997; 20: 519 – 26.
- 23.
Murialdo G, Galimberti CA, Gianelli MV, Rollero A, Polleri A, Copello F et al. Effects of valproate, phenobarbital, and carbamazepine on sex steroid setup in women with epilepsy. Clin Neuropharmacol 1998; 21: 52 – 8.
- 24.
Taubøll E, Harbo HF, Isojärvi JIT, Gjerstad L, Dale PO, Pakarinen AJ. Endocrine effects of valproate studied in norwegian female epilepsy patients and in an experimental animal model. Acta Neurol Scand 1998; 97: 342.
- 25.
O’Donovan C, Kusumakar V, Graves G, Bird D. Menstrual abnormalities and polycystic ovary syndrome in women taking valproate for bipolar mood disorder. J Clin Psychiatry 2002; 64: 322 – 30.
- 26.
Rättyä J, Vainonpää L, Knip M, Lanning P, Isojärvi JIT. The effects of valproate, carbamazepine, and oxcarbazepine on growth and sexual maturation in girls with epilepsy. Pediatrics 1999; 103: 588 – 93.
- 27.
Vainionpää LK, Rättyä J, Knip M, Tapanainen JS, Pakarinen AJ, Lanning P et al. Valproate-induced hyperandrogenism during pubertal maturation in girls with epilepsy. Ann Neurol 1999; 45: 444 – 50.
- 28.
Taubøll E, Isojärvi JIT, Harbo HF, Pakarinen AJ, Gjerstad L. Long-term valproate treatment induces changes in ovarian morphology and serum sex steroid hormone levels in female Wistar rats. Seizure 1999; 8: 490 – 3.
- 29.
Røste LS, Taubøll E, Berner A, Isojärvi JIT, Gjerstad L. Valproate, but not lamotrigine, induced ovarian morphological changes in Wistar rats. Exp Toxicol Pathol 2001; 52; 545 – 52.
- 30.
Røste LS, Taubøll E, Isojärvi JIT, Pakarinen AJ, Huhtaniemi I, Gjerstad L. Effects of chronic valproate treatment on reproductive endocrine function in female and male Wistar rats. Reprod Toxicol 2002; 16: 767 – 73.
- 31.
Taubøll E, Wójtowicz AK, Ropstad E, Gregoraszczuk EL. Valproate irreversibly alters steroid secretion patterns from porcine follicular cells in vitro. Reprod Toxicol 2002; 16: 319 – 25.
- 32.
Taubøll E, Gregoraszczuk EL, Kolodziej A, Kajta M, Ropstad E. Valproate inhibits the conversion of testosterone to estradiol and acts as an apoptotic agent in growing porcine ovarian follicular cells. Epilepsia, akseptert for publisering, 2003.
- 33.
Isojärvi JIT, Rättyä J, Myllylä VV, Knip M, Koivunen R, Pakarinen AJ et al. Valproate, lamotrigine, and insulin-mediated risks in women with epilepsy. Ann Neurol 1998; 43: 446 – 51.
- 34.
Bauer J, Jarre A, Klingmüller D, Elger CE. Polycystic ovary syndrome in patients with focal epilepsy: a study in 93 women. Epilepsy Res 2000; 41: 163 – 7.
- 35.
Bilo L, Meo R, Valentino R, Di Carlo C, Striano S, Nappi C. Characterizaton of reproductive endocrine disorders in women with epilepsy. J Clin Endocrinol Metab 2001; 86; 2950 – 6.
- 36.
Yerby MS. Special considerations for women with epilepsy. Pharmacotherapy 2000; 20 (8 Pt 2): 159 – 70.
- 37.
Laidlaw J. Catamenial epilepsy. Lancet 1956; 271; 1235 – 7.
- 38.
Taubøll E, Lundervold A, Gjerstad L. Temporal distribution of seizures in epilepsy. Epilepsy Res 1991; 8: 153 – 65.
- 39.
Duncan S, Read CL, Brodie MJ. How common is catamenial epilepsy? Epilepsia 1993; 34: 827 – 31.
- 40.
Herzog AG, Klein P, Ransil BJ. Three patterns of catamenial epilepsy. Epilepsia 1997; 38: 1082 – 8.
- 41.
Zahn C. Catamenial epilepsy: clinical aspects. Neurology 1999; 53 (suppl 1): 34 – 7.
- 42.
Logothetis J, Harner R, Morrell F, Torres F. The role of estrogens in catamenial exacerbation of epilepsy. Neurology 1959; 9: 352 – 60.
- 43.
Marcus EM, Watson CW, Goldman PL. Effects of steroids on cerebral electrical activity. Arch Neurol 1966; 15: 521 – 32.
- 44.
Majewska MD, Harrison NL, Schwartz RD, Barker JL, Paul SM. Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science 1986; 232: 1004 – 7.
- 45.
Landgren S, Aasly J, Bäckström T, Dubrovsky B, Danielsson E. The effect of progesterone and its metabolites on interictal epileptiform discharge in the cat’s cerebral cortex. Acta Physiol Scand 1987; 131: 33 – 42.
- 46.
Taubøll E, Gjerstad L. Comparison of 5a-pregnan-3a-ol-20-one and phenobarbital on cortical synaptic activation and inhibition studied in vitro. Epilepsia 1993; 34: 228 – 35.
- 47.
Taubøll E, Lindström S. The effect of progesterone and its metabolite 5a-pregnan-3a-ol-20-one on focal epileptic seizures in the cat"s visual cortex in vivo. Epilepsy Res 1993; 14: 17 – 30.
- 48.
Betts T, Crawford P. Women and epilepsy. London: Martin Dunitz, 1998, 1 – 84.
- 49.
Herzog AG. Hormones and epilepsy. Acta Neurol Scand 2000; 102 (suppl 175): 29 – 31.
- 50.
Feely M, Calvert , Gibson J. Clobazam in catamenial epilepsy: a model for evaluating anticonvulsants. Lancet 1982; 2: 71 – 3.
- 51.
Guberman A. Hormonal contraception and epilepsy. Neurology 1999; 53 (suppl 1): 38 – 40.
- 52.
Lambert MV. Seizures, hormones and sexuality. Seizure 2001; 10: 319 – 40.
- 53.
Morrell MJ. Sexuality in epilepsy. I: Engel J, Pedley T, red. A Comprehensive textbook of epilepsy. Philadelphia: Lippincott-Raven, 1997: 2021 – 6.
- 54.
Toone B. Epilepsy and sexual life. I: Hopkins A, Shorvon S, Cascio G, red. Epilepsy. 2. utg. London: Chapman & Hall, 1995: 557 – 64.
- 55.
Morrell MJ. Managing epilepsy in women across the reproductive cycle. A CME monograph for neurologists. Secaucus, NJ: Projects in knowledge, 2001: 1 – 30.
- 56.
Stoffel-Wagner B, Bauer J, Flügel D, Brennemann W, Klingmüller D, Elger CE. Serum sex hormones are altered in patients with chronic temporal lobe epilepsy receiving anticonvulsant medication. Epilepsia 1998; 39: 1164 – 73.
- 57.
Morrell MJ, Sperling MR, Stecker M, Dichter MA. Sexual dysfunction in partial epilepsy: a deficit in physiological sexual arousal. Neurology 1994; 44: 243 – 7.
- 58.
Morrell MJ, Springer E, Guidice L. Reproductive function in women with epilepsy on inducing and noninducing antiepileptic drugs. Epilepsia 1997; 38 (suppl 8): 232.
- 59.
Taylor DC. Sexual behavior and temporal lobe epilepsy. Arch Neurol 1969; 21: 510 – 6.
- 60.
Jensen P, Jensen SB, Sorensen PS, Bjerre BD, Rizzi DA, Sorensen AS et al. Sexual dysfunction in male and female patients with epilepsy: a study of 86 outpatients. Arch Sex Behav 1990; 19: 1 – 14.
- 61.
Blumer D, Walker AE. Sexual behavior in temporal lobe epilepsy. Arch Neurol 1967; 16: 37 – 43.
- 62.
Morrell MJ, Guldner G. Self reported sexual function and sexual arousability in women with epilepsy. Epilepsia 1996; 37: 1204 – 10.
- 63.
Demerdash A, Shaalan M, Midani A, Kamel F, Bahri M. Sexual behavior of sample of females with epilepsy. Epilepsia 1991; 32: 82 – 5.
- 64.
Duncan S, Blacklaw J, Beastall GH, Brodie MJ. Sexual function in women with epilepsy. Epilepsia 1997; 38: 1974 – 81.
- 65.
Klein P, Serje A, Pezzullo JC. Premature ovarian failure in women with epilepsy. Epilepsia 2001; 42: 1584 – 9.
- 66.
Harden CL, Nikolov BG, Koppel BS, Rivera N, Duryer AL, Labar DR et al. Seizure frequency and age of menopause in women with epilepsy. Epilepsia 2001; 42 (suppl 7): 291.
- 67.
Lee MA. Epilepsy in the menopause. Neurology 1999; 53 (suppl 1): 41.
- 68.
Harden CL, Pulver MC, Ravdin L, Jacobs AR. The effect of menopause and perimenopause on the course of epilepsy. Epilepsia 1997; 38 (suppl 8): 133 – 4.
- 69.
Harden CL, Pulver MC, Ravdin L, Jacobs AR. The effect of menopause and perimenopause on the course of epilepsy. Epilepsia 1999; 40: 1402 – 7.
- 70.
Pack AM, Morrell MJ. Adverse effects of antiepileptic drugs on bone structure: epidemiology, mechanisms and therapeutic implications. CNS Drugs 2001; 15: 633 – 42.
- 71.
Abbasi F, Krumholz A, Kittner SJ, Langenberg P. Effects of menopause on seizures in women with epilepsy. Epilepsia 1999; 40: 205 – 10.
()
Denne artikkelen ble publisert for mer enn 12 måneder siden, og vi har derfor stengt for nye kommentarer.